Discover how the PRCP enzyme acts as a master regulator in non-small cell lung cancer, controlling tumor growth through angiotensin II regulation.
Explore how microRNAs and machine learning algorithms like SVM are revolutionizing lung cancer detection through non-invasive blood tests.
Discover how MUC1 protein and the MAPS signature predict lung adenocarcinoma outcomes and revolutionize cancer treatment approaches.
Exploring how biologistics and compact technology are transforming lung cancer screening through efficient logistics and advanced instrumentation.